Have You Heard? Jaypirca is Now Approved for R/R CLL!

Classes Oncology Have You Heard? Jaypirca is Now Approved for R/R CLL!

Instructions

Please Sign in to your account to see the Class.

Jaypirca is now approved as first reversible BTK inhibitor for patients with R/R CLL, learn more today.